Institute for Systems Biology focuses on some of the most pressing issues in human health, including cancer and brain health. ISB President and Professor James Heath, PhD, is a PICI investigator who bridges cutting-edge technology and immune system biology. He builds new technologies to investigate how individual patients’ immune systems respond to therapeutic interventions including vaccines, checkpoint blockade and CAR-T cell therapy. He collaborates with PICI in high-need areas, pushing progress in glioblastoma and brain tumor research. James Heath, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Announcement, Press Release First Patients Dosed in Pancreatic Platform Trial Partner Highlight Connecting Patients with Innovative Immunotherapies Our Impact, Partner Highlight All the Right Ingredients: The Founders of ArsenalBio Partner Highlight, Press Release NanoString and PICI Partner to Optimize Cell Therapies Announcement, Research Update Five Key Takeaways from ASCO 2021 Cancer Research Heroes, Patient Story When Cancer Becomes A Calling: Lacey Kitch Research Project Pancreatic Cancer Program